Star Equity Holdings, Inc. · NASDAQ:STRR

Star Equity — Digirad — Merger or Acquisition (October 2015)

9 slides from Star Equity's merger presentation, Oct 14, 2015

  1. Slide 1: DMS Health Technologies, Inc. Acquisition Overview

    DMS Health Technologies, Inc. ACQUISITION OVERVIEW OCTOBER 14, 2015 Exhibit 99.2

  2. Slide 2: Forward-Looking Statements

    FORWARD-LOOKING STATEMENTS “Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995: The presentation and information contained herein contain statements that are forward-looking statements as defined within the Private Securities Litigation Reform Act of 1995. Some of thes

  3. Slide 3: Digirad Strategy Update

    ~ EOY 2015: •Proposed Acquisition of DMS Health Technologies •~$65+ Million in Revenue •Expands Service Offerings, Geographies and Customer Base February 2013: •Core Business Restructured •Return to Profitability Digirad Strategy Update 3 Since Digirad’s restructuring in early 2013, we have focused

  4. Slide 4: DMS Health Technologies Overview

    DMS Health Technologies Overview 4 DMS Health Technologies (DMS Health) is an integrated health care services company headquartered in Fargo, ND providing mobile, fixed-site, and interim imaging as well as imaging and related equipment product sales and support. ● DMS Health Mission:  Improve healt

  5. Slide 5: DMS Health Technologies Overview: Divisions

    DMS Health Technologies Overview 5 DMS Health Technologies, Inc. 2014 Revenue: ~$65M DMS Imaging Division Medical Equipment Services Division Medical Equipment Product Sales Division ● Mobile Imaging  PET/CT  MRI  CT  Nuclear Medicine  Mammography ● Fixed Site Imaging ● Interim / Short Term Ima

  6. Slide 6: Pro Forma Customer Map

    Pro Forma Customer Map 6 ● The combined Digirad entity will support customers in 42 states ● Though there is some minor overlap in some states, DMS Health’s highest customer concentrations are in the upper Midwest – all new territory for Digirad ● The long-term benefit will be the ability to leverag

  7. Slide 7: Pro Forma Combined Company

    Pro Forma Combined Company 7 The combined Digirad entity is anticipated to have the following pro forma metrics once closed: ● Annual Revenues: Over $125 Million ● Annual Adjusted EBITDA: Over $17 Million ● Employees: ~650 ● US States Served: 42 ● Annual Dividend Rate Per Share: $0.20

  8. Slide 8: Key Deal Terms

    Key Deal Terms 8 Stock Purchase Agreement ● Purchase Price. $36 Million, all cash. ● Closing Conditions. Customary for a transaction of this type. ● Expected Closing. By December 31, 2015. ● Acquisition Funding. Combination of cash on hand and financing arrangement. Digirad Financing Arrangement ● T

  9. Slide 9: Key Benefits of DMS Health

    Key Benefits of DMS Health 9 ● Geography. DMS Health has a strong presence in the upper Midwest – which overlays very well with Digirad, with no current services in the area; expanding geographic opportunities for both companies. ● Modalities. PET/CT, MRI, and CT make up the majority of DMS Health’s

Digirad — Merger or Acquisition (October 2015) on 6ix